Drug discovery: playing dirty

Nature. 2005 Oct 13;437(7061):942-3. doi: 10.1038/437942a.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • Benzamides
  • Cardiovascular Diseases / drug therapy
  • Clinical Trials as Topic
  • Clozapine / pharmacology
  • Depression / drug therapy
  • Drug Approval
  • Drug Design*
  • Drug Evaluation, Preclinical
  • Drug Industry / methods*
  • Drug Industry / trends*
  • Gefitinib
  • Humans
  • Imatinib Mesylate
  • Neoplasms / drug therapy
  • Piperazines / pharmacology
  • Pyrimidines / pharmacology
  • Quinazolines / pharmacology
  • Sensitivity and Specificity
  • Substrate Specificity
  • Therapeutics / methods
  • Therapeutics / trends*
  • United States
  • United States Food and Drug Administration

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Quinazolines
  • Imatinib Mesylate
  • Clozapine
  • Gefitinib